International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: 10.5281/zenodo.12787768
Original Research Article
Evaluating the Diagnostic Precision of Digital Radiography and Ultrasound in Paediatric Pneumonia
Published
Sept. 25, 2024
Abstract

Pediatric pneumonia remains a significant health concern, contributing to high morbidity and mortality rates in children, especially those under five years of age. This study aims to evaluate and compare the diagnostic precision of digital radiography (Xray) and ultrasound in diagnosing pediatric pneumonia among children aged 0-12 years at ShriVasantraoNaik Government Medical College, Yavatmal, from January 2022 to June 2024. A prospective observational study included 50 pediatric patients clinically suspected of pneumonia. Both diagnostic modalities were performed, and their sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. Ultrasound exhibited higher sensitivity (90%) and specificity (95%) compared to digital radiography, which had a sensitivity of 80% and specificity of 90%. The results underscore ultrasound's advantage due to its radiation-free nature, making it particularly suitable for the pediatric population. Strong interobserver agreement was noted for both modalities. The findings indicate that a combination of clinical evaluation and appropriate imaging can enhance the management and timely diagnosis of pneumonia in children.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
15 Views
320 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved